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A B S T R A C T
Resveratrol is a plant secondary metabolite commonly found in peanuts and grapevines with signiﬁcant
health beneﬁts. Recombinant organisms can produce large amounts of resveratrol and, in this work,
Escherichia coli BW27784was used to produce resveratrol in bioreactorswhilemonitoring cell physiology
and plasmid stability through ﬂow cytometry and real-time qPCR, respectively. Initially, the inﬂuence of
culture conditions and precursor addition was evaluated in screening assays and the data gathered was
used to perform the bioreactor assays, allowing the production of 160mg/mL of resveratrol. Cellular
physiology and plasmid instability affected the ﬁnal resveratrol production, with lower viability and
plasmid copy numbers associatedwith lower yields. In sum, this study describes new tools tomonitor the
bioprocess, evaluating the effect of culture conditions, and its correlation with cell physiology and
plasmid segregational stability, in order to deﬁne a viable and scalable bioprocess to fulﬁll the need for
larger quantities of resveratrol.
ã 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
Resveratrol (3,5,40-trans-hydroxystilbene) is a phytoalexin and
a polyphenolic compound that belongs to the stilbene family [1].
This natural occurring and multi-biofunctional chemical [2] exists
in both cis- and trans- isomeric forms due to its two phenol rings
linked by a styrene double bond [3]. Resveratrol is produced by
plants in response to biotic and abiotic stress and has been used as
a folk remedy to treat various ailments. Several biological
properties have been associated with the use of resveratrol,
namely cardio and neuroprotective effects [4,5], anticancer, and
antimicrobial [6,7] as well as the ability to prolong lifespan [8].
Based on its presumed properties, the interest in resveratrol by
the pharmaceutical, nutraceutical, and cosmetic industries is
increasing [9]. Resveratrol used by these industries is generally
chemically synthesized through several routes [10]. As chemical
synthesis is a time-consuming process [10] thatmay be affected by
the low reactivity of reagents, more sustainable alternatives to
chemical synthesis are in demand for resveratrol production. In
order to overcome these hurdles, new biological-based processes
using plant cell systems and recombinant microorganisms are
being evaluated to produce resveratro [19]. Despite the high
resveratrol amounts produced by Saccharomyces cerevisiae [11],
Escherichia coli is the recombinant microorganism of choice due to
its ability to quickly produce this compound [9], sometimes in
large amounts, as has been described in previous studies [12].
Process productivity can be severely affected by cell physiology and
plasmid stability [14], due to decreased cell growth, as a result of
lower cell viability, or due to lower enzyme quantities, as a result of
decreased plasmid copy number or gene expression [15]. So, in
order to optimize resveratrol production and to guarantee the
maximal output of the process, the assessment of cultivation
conditions and other process variables effect in cell physiology and
plasmid segregational stability is of vital importance [13]. The
present work describes resveratrol production in bioreactor using
E. coli BW27784 transformed with pAC-4CL1 and pUC-STS
plasmids while monitoring cell physiology and plasmid segrega-
tional stability through ﬂow cytometry and real-time qPCR,
respectively, in order to evaluate whole process performance.
2. Materials and methods
2.1. Plasmid, bacterial strain, and growth conditions
The bacterial host E. coli BW27784 (E. coli Genetic Stock Center,
New Haven, CT, USA) was transformed with pAC-4CL1 plasmid
(Addgene plasmid 35,947, Cambridge, MA, USA) encoding for
4-coumaroyl CoA ligase from Arabidopsis thaliana and pUC-STS
plasmid (Addgene plasmid 35,949, Cambridge, MA, USA) encoding
for stilbene synthase from Arachis hypogaea [16]. Plasmid
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pAC-4CL1 has a p15A origin with the genes coded by the plasmid
being constitutively expressed. pUC-STS has a pBR322 origin of
replication and the genes carried by this plasmid were also
constitutively expressed from the lac promoter [16]. E. coli was
genetically manipulated using transformation by the heat shock
protocol. Brieﬂy, the competent cells were generated by addition
of magnesium chloride (100mM) and calcium chloride (100mM in
the ﬁrst step and 85mM in the second step of the protocol) to
E. coli cells obtained from a LB medium cultivated at 37 C. Then,
the suspension was incubated on ice for 25min and the pellet
was collected. The transformation was performed by addition of
1mL of each plasmid, followed by incubation on ice for 30min,
heating at 42 C for 30 s and subsequent transfer to ice. 200mL of
SOC medium were added to the previous suspension and
incubated at 37 C. For selection of transformants, this suspension
was spread in LB plates containing 50mg/mL chloramphenicol
and 100mg/mL ampicillin. The expression system was cultivated
in M9 medium (per 1 L of water: 6.779g of Na2HPO4, 3 g of
KH2PO4, 0.5 g of NaCl, 1 g of NH4Cl, 1.25 g of yeast extract, 5 g of
glycerol, 2mL of MgSO47H2O 1M, and 0.1mL of CaCl22H2O 1M)
[16]. All cultures were started with an OD600 of 0.05, grown
in 250mL shake ﬂasks containing 62.5mL of medium, with
50mg/mL chloramphenicol, and 100mg/mL ampicillin, at 250 rpm
and 30 C.
2.2. Screening assays
In order to establish working ranges for further experiments,
four factorswere tested in screening assays: precursor (p-coumaric
acid) concentration (0–20mM), OD600 at time of precursor
addition (0.1–1), temperature (25–42 C), and pH (5–9).
p-Coumaric acid was dissolved in DMSO to a ﬁnal concentration
of 1M and sterilized by using a 0.22mm pore size ﬁlter. Growth
was suspended after 48h of fermentation.
2.3. Bioreactor assays
E. coli was cultivated in four 0.5 L working volume parallel
bioreactor (Infors HT, Bottmingen, Switzerland) containing 250mL
of M9 medium. The bioreactors were operated with strictly
controlled parameters including pH, temperature, airﬂow, agita-
tion (250 rpm) and dissolved oxygen (30%). The pHwasmaintained
through the automatic addition of 1MNaOHand 1MH2SO4. All the
parameters were monitored continuously using the IRIS software
(Infors HT, Bottmingen, Switzerland) and all cultures were
performed under subdued light in order to avoid trans-resveratrol
isomerization to cis-resveratrol. Fermentations were carried out
for 30h and samples were taken aseptically at 22 and 30h of
fermentation to control growth and to evaluate resveratrol
production, cell physiology and plasmid stability. The dry cell
weight was calculated based on the previous established relation
between OD600 and dry cell weight where one unit of OD600 was
found to correspond to a dry cell weight of 0.25 g/L [17].
2.4. Analytical chromatography
Prior to injection, resveratrol was extracted from cell-free
culture supernatant using a liquid–liquid extraction with ethyl
acetate. Brieﬂy, 1mL of culture broth was centrifuged at
13,000 rpm for 5min. The resulting supernatant was mixed with
50mL of hydrochloric acid and carbamazepine (internal standard
(IS), 100mg/mL ﬁnal concentration) and extracted with 1mL of
ethyl acetate. The extraction mixture was dried at 30 C under a
nitrogen gas stream, dissolved in 100mL of mobile phase [18] and
ﬁltered through a 0.22mm pore size ﬁlter. Each sample was
analyzed in triplicate and all sampleswere stored at20 C prior to
HPLC analysis to prevent resveratrol degradation. TenmL of extract
were applied to a Zorbax 300SB-C18 reverse-phase analytical
column (4.6mm ID150mm, Agilent Technologies, Santa Clara,
CA, USA) using an Agilent 1200UPLC system equippedwith a diode
array detector. The process was performed as described in Paulo
et al. [18], with a ﬂow rate of 1mL/min. Standard curves were
constructed by plotting the area ratio between resveratrol and IS
versus resveratrol concentration. All resveratrol analyses were
performed in triplicate at each fermentation time.
2.5. Flow cytometry
Samples were analyzed on a CyAn ADP (Beckman Coulter, Brea,
CA, USA) ﬂow cytometer equipped with a 20mW semiconductor
laser at 488nm. Fluorescence (FL1 and FL3 bandpass ﬁlters) and
light scatter (FSC and SSC) signals were acquired logarithmically.
Acquisition was performed with Summit 4.3 (Beckman Coulter,
Brea, CA, USA) software. To reduce electronic and small particle
noise, threshold levels were set on SSC. For the evaluation of cell
viability, a bis-(1,3-dibutylbarbituric acid) trimethine oxonol (BOX,
2.5mg/mL ﬁnal concentration) and propidium iodide (PI, 10mg/mL
ﬁnal concentration) dual staining was performed as previously
described [13]. The ﬂuorescence signals were collected by FL1
(BOX) and FL3 (PI) bandpass ﬁlters and 5000 events/cells were
acquired for each sample.
2.6. Real-time qPCR
Fermentation samples for real-time qPCR were prepared as
previously described [13]. Speciﬁc primers (Stab Vida, Lisboa,
Portugal) for chloramphenicol resistance gene (forward: 50-
ACCGTAACACGCCACATCTT-30; reverse: 50-TTCTTGCCCGCCTGAT-
GAAT-30) and ampicillin resistance gene (forward: 50-TCCTTGA-
GAGTTTTCGCCCC-30; reverse: 50-TTCATTCAGCTCCGGTTCCC-30)
were used to amplify fragments in each of the two plasmids
used. Real-time qPCR efﬁciency was determined for this primer
set using standard solutions of known plasmid copy number.
Real-time qPCR (IQ5 Biorad, Hercules, CA, USA) reactions were
performed using 3mL of sample for a 20mL reaction containing
10mL of MaximaTM SYBR Green qPCR Master Mix (Fermentas,
Burlington, ON, Canada) and, 400nM of pAC-4CL1 or 200nM of
pUC-STS primer set. Regarding pUC-STS, reactions were incubated
at 95 C for 3min, followed by 30 cycles of 10 s at 95 C and 30 s at
58 C. For pAC-4CL1, reactions were incubated at 95 C for 3min,
followed by 30 cycles of 10 s at 95 C and 30 s at 60 C. The
ampliﬁed PCR fragments were checked by melting curves:
reactions were heated from 55 to 95 C with 10 s holds at each
temperature (0.05 C/s). Bacterial cell concentration was kept
constant at 3104 cells/reaction and for each fermentation
sample, triplicate measurements were performed. PCN standards
for calibration curve were made according to a previously
described method [13]. Acquisition and analysis were performed
in BioRad IQ 5 Software, Hercules, CA, USA.
3. Results and discussion
3.1. Screening assays
In order to determine the most relevant parameters and their
ranges for resveratrol production in bioreactors, a set of screening
assays was performed and the results are summarized in Fig. 1. In
these assays, four parameters were evaluated: concentration of
p-coumaric acid added, optical density (OD600) of the culturewhen
this addition was performed, incubation temperature, and pH.
The strategy used in these screening assays was based on a
selection of baseline set of levels for each factor (1mMof precursor
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added at OD600 of 0.1 in M9 medium at 30 C, pH 7, and 250 rpm).
Then, successively, each factor was varied over its range, while
keeping the other factors constant. These screening assays allowed
the attainment of amaximumyield of approximately 100mg/mL of
resveratrol.
Six concentrations of p-coumaric acid were tested ranging from
0 to 20mM. These concentrations were selected based on previous
experiments [16]. Due to the limited aqueous solubility of
p-coumaric acid, its maximum concentration was chosen in order
to allow a proper dissolution in the aqueous culture medium [16].
It was observed that, if p-coumaric acid was above a concentration
of 10mM, resveratrol production and cell growth started to
decrease, which could be associated with the possible inhibitory
effect on cell functions produced by higher p-coumaric acid
concentrations [19]. The addition of 1mM to 10mM of p-coumaric
acid yielded the highest results; however, low concentrations
may be preferable in this situation due to the detrimental effects of
p-coumaric acid in both production and growth. Regarding the
OD600 of the culture at the time of precursor addition, the highest
resveratrol concentrations were obtained between an OD600 of
0.5 and 1, which means that the addition of precursor in the early
stages of growth may affect E. coli growth at lag phase. Lou et al.
[20] observed that Gramnegative bacteria treatedwith p-coumaric
acid presented slight leakages of cellular cytoplasmic contents only
90min after treatment, which may consequently affect resveratrol
production.
Finally, with respect to the culture conditions evaluated, the
best temperature for trans-resveratrol production seemed to be
30 C, as higher temperatures (37 and 42 C), although allowing
higher cell growth, yielded lower resveratrol concentrations. This
decrease in trans-resveratrol production at higher temperatures
might be associated with the possible degradation of this
compound if subjected to higher temperatures [21], as shown
in a previous study [22] that demonstrated trans-resveratrol
degradation for temperatures over 35 C. Regarding the initial pH, a
value of 7.0 allowed the achievement of the highest resveratrol
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Fig. 1. Inﬂuence of p-coumaric acid concentration (A), optical density (OD600) at addition of precursor (B), temperature (C), pH (D) on resveratrol production in the screening
assays andmaximumproduction obtained (E), with the level and optical density corresponding to themaximumobtained in each factor, in a 48h fermentation. The values are
presented as mean SD of three measurements.
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yield. Taking into account that resveratrol is stable in a wide pH
range [23], up to a pH of 9.0, above which the deprotonating of
resveratrol occurs [24], the highest yield obtained at a pH of 7.0
may be related with the fact that this is the optimal pH for E. coli
growth.
3.2. Bioreactor assays
Table 1 lists the conditions used in the assays of resveratrol
production scale-up performed in bioreactor. The values for the
conditions tested were established considering the results
obtained in the screening assays. The range of values was
established in order to assess the inﬂuence of each parameter in
ﬁnal resveratrol production and cell physiology. The inﬂuence of
the conditions tested on resveratrol yield and productivity, cell
growth and viability and plasmid segregational stability can be
seen on Table 2.
As expected, if the concentration of precursor added was 0mM
(assay 11), the production is approximately null. It was also
observed that low concentrations of resveratrol were generally
associated with higher concentrations of precursor, as a concen-
tration of 12mM of p-coumaric acid allowed the attainment of a
resveratrol productivity of 2.98mg/gh1 (assay 5) while a
concentration of 4mM allowed an almost two-fold increase of
resveratrol productivity to 5.09mg/gh1 (assay 3), with the same
correlation being obtained in terms of resveratrol volumetric
yields. It can also be observed that p-coumaric acid seemed to have
a detrimental effect on cellular growth, as higher concentrations of
p-coumaric acid added resulted in lower OD600 values (assays 4, 5,
8, 9, and 15) when compared to assays without or with lower
concentrations of p-coumaric acid (assays 2, 3, 6, 7, and 11). The
inﬂuence of temperature can be seen by the resveratrol yield
analysis when observing the assays results for 25, 31, and 37 C
with the other variables constant (assay 1, 13 and 25, respectively).
It was observed that for the lowest (25 C) and highest (37 C)
tested temperatures, resveratrol production was low, with the
best results, both in terms of volumetric yield and productivity
being achieved for assays at 28 and 31 C (assays 2–16), thus
corroborating the results obtained for this parameter in the
screening assays. However, at 25 C (assay 1, Table 2), E. coli did not
produce high amounts of resveratrol as 25 C is not within the
E. coli optimal growth range, which can result in slower transport
processes and growth [25], and consequently lower resveratrol
production. Although 37 C is the temperature closer to the
optimum E. coli growth temperature [25] this temperature may
lead to trans-resveratrol degradation [22], since it is an easily
degradable compound [21], which resulted in lower production
levels. Regarding the pH, a pH around 6.5–7.0 seemed to be an
optimal value to produce resveratrol, since the production tripled
from 32.53mg/mL, at a pH of 6.0 (assay 10), to 100.59mg/mL, at a
pH of 7.0 (assay 13) and then decreased again to 26.32mg/mL
(assay 16), at a pH of 8.0. The same trend was also observed for
resveratrol speciﬁc values that almost tripled from 1.37 (pH 6.0) to
3.44 (pH 7.0) and then decreased again to 1.24 (pH 8.0). This pH
inﬂuence on resveratrol production could be related with the
optimal pH for E. coli growth as seen in the screening assays. In
these assays, the OD600 at the time of induction had a slight impact
on ﬁnal production. This can be seen in assays 12–14, where the
highest and lowest OD600 were tested (1.025 and 0.125, respec-
tively) and also an intermediate value (0.575, assay 13). Although
resveratrol production in assays 12 and 14 did not differmuch from
each other, after 30h of growth, in assay 13, higher values of
resveratrol production were achieved, highlighting the fact that
the precursor should be added at the beginning of the exponential
phase of growth to prevent early leakages, ruptures, and general
damage to the membrane [20] and consequent decrease in
resveratrol production. It can be seen that the best resveratrol
productivity (6.31mg/gh1, assay 15) was obtained at 31 C, pH 7.0,
with a precursor concentration of 16mM added at an OD600 of
0.575, which highlights the relevance of extending the range of
conditions. On the other hand, the highest resveratrol production
(159.96mg/mL, assay 3) was achieved at 28 C, pH 6.5, with a
precursor concentration of 4mM added at an OD600 of 0.8. These
discrepancies in resveratrol production yields can be partially
explained by the very distinct OD600 values obtained for assays
3 and 15 (4.19, and 2.31, respectively). However, the assay with the
most similar conditions to those achieved in the screening assays
(assay 13) still exhibited a value (100.59mg/mL) close to the one
obtained in the screening assays and in another study [16],
indicating that this is a very reproducible process, which is of vital
importance when designing an industrial fermentation process.
Since process productivity can be affected by plasmid segrega-
tional stability and physiological states of cells [14] due to decrease
plasmid and/or protein levels and cellular growth, these two
parameters were monitored for each of these bioreactor assays.
3.3. Cellular viability
In order to assess cell physiology, a PI/BOX dual-staining was
performed. BOXwas used to evaluate membrane potential, since it
accumulates intracellularly when the cytoplasmic membrane is
depolarized, and PI was used to verify themembrane integrity, as it
only enters the cell if the membrane is injured. Overall, the
percentage of healthy cells decreased throughout the fermenta-
tion, as the percentage of depolarized (BOX-positive) cells globally
showed a marked increase from 22 to 30h of fermentation
(Table 2). Although the vast majority of the cells was in a healthy
state, this percentage is smaller when compared to the values
obtained in other bioprocess monitoring studies [13]. The higher
values of depolarized cells may be due to the fact that M9medium
is a minimal medium [26], which limits nutrient availability and
causes an increase in cell depolarization due to nutrient starvation
[13]. With respect to the inﬂuence of cellular viability on growth,
lower percentages of healthy cells seem to correspond to lower
Table 1
Description of bioreactor conditions: temperature, pH, precursor (p-coumaric acid)
concentration, and optical density at time of precursor addition (OD600) for each of
the fermentation assays.
Assay Temperature (C) pH Precursor
concentration (mM)
OD600
1 25 7 8 0.575
2 28 6.5 4 0.35
3 28 6.5 4 0.8
4 28 6.5 12 0.35
5 28 6.5 12 0.8
6 28 7.5 4 0.35
7 28 7.5 4 0.8
8 28 7.5 12 0.35
9 28 7.5 12 0.8
10 31 6 8 0.575
11 31 7 0 0.575
12 31 7 8 0.125
13 31 7 8 0.575
14 31 7 8 1.025
15 31 7 16 0.575
16 31 8 8 0.575
17 34 6.5 4 0.35
18 34 6.5 4 0.8
19 34 6.5 12 0.35
20 34 6.5 12 0.8
21 34 7.5 4 0.35
22 34 7.5 4 0.8
23 34 7.5 12 0.35
24 34 7.5 12 0.8
25 37 7 8 0.575
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Table 2
Values of optical densities, resveratrol production yields, cellular viability (PI and BOX positive cells), and plasmid copy number obtained in each of the bioreactor assays described in Table 1 after 22 and 30h of fermentation.
Assay OD600 Resveratrol volumetric yield (mg/mL) Resveratrol productivity
(mg/gh1)
Cellular viability Plasmid copy number (PCN)
PI+(%) BOX+(%) pAC-4CL1 pUC-STS
22h 30h 22h 30h 22h 30h 22h 30h 22h 30h 22h 30h 22h 30h
1 1.84 2.53 57.942.44 69.171.34 5.730.16 3.650.31 1.48 1.43 23.31 29.7 2610.60 280.96 254.09 3010.15
2 2.77 4.43 84.19.49 153.731.08 5.521.27 4.631.90 5.56 7 21.32 15.02 11547.14 13014.93 202.18 265.44
3 2.72 4.19 86.36.41 159.962.86 5.770.48 5.090.96 4.3 7.06 21.66 18.08 21584.94 24236.44 7216.10 8915.53
4 2.24 2.73 23.510.31 46.070.65 1.910.52 2.250.27 0.28 1.48 30.23 27.68 4715.48 779.61 9546.53 8611.48
5 2.35 2.9 39.383.02 64.722.24 3.050.02 2.980.03 1.18 3.78 18.84 20.38 297.25 7736.28 2211.15 359.34
6 2.76 4.44 39.481.47 65.540.63 2.600.44 1.970.88 1.88 3.1 18.58 20.5 2823.60 4015.39 40.71 41.25
7 2.76 4.42 41.712.89 97.565.61 2.750.06 2.940.08 2.08 3.7 16.08 14.08 3012.76 4721.25 233.87 146.76
8 2.13 3.35 401.08 79.323.62 3.410.37 3.160.55 3.12 3.7 9.9 13.94 5114.66 625.71 156.66 142.27
9 2.56 2.86 28.570.28 50.681.88 2.030.32 2.360.09 1.17 1.26 30.95 26.7 337.63 3617.88 456.66 622.27
10 2.04 3.16 28.665.05 32.533.64 2.550.33 1.370.16 5.62 5.1 19.86 16.14 21854.82 39474.85 919.32 6411.60
11 4.5 4.9 1.530.27 3.112.32 0.060.01 0.080.01 3.12 2.4 21.3 27.34 11773.19 5316.91 3122.22 6230.71
12 2.68 3.02 56.453.06 69.875.27 3.830.97 3.080.50 1.37 2.13 23.42 27.08 5124.16 8211.03 12841.38 20657.15
13 2.78 3.9 74.341.92 100.597.83 4.860.75 3.441.35 2.3 2.42 24.42 18.8 346.40 447.86 7821.13 16073.50
14 2.54 3.41 23.714.15 78.015.08 1.700.43 3.050.47 1.24 2.83 27.63 33.04 644.93 814.69 17735.29 23934.75
15 2.24 2.31 52.249.92 109.282.44 4.240.15 6.310.69 1.87 2.94 24.9 31.11 4810.12 6713.21 10353.40 13581.07
16 1.42 2.82 22.211.72 26.320.86 2.840.28 1.240.85 3.76 6.13 19.82 30.87 816.62 1139.87 4414.56 697.81
17 4.65 4.64 32.371.92 35.062.80 1.270.03 1.010.16 3.9 5.9 22.8 43.2 642.01 9418.35 6978.15 5924.94
18 4.04 3.97 58.520.53 61.990.99 2.630.03 2.080.42 4.58 8.28 23.98 32.9 5530.94 968.80 2811.43 337.82
19 1.82 3.1 9.320.75 13.410.97 0.930.21 0.580.46 3.14 4.32 10.02 16.78 8427.46 445.94 404.00 214.95
20 3.09 3.59 17.511.22 15.900.17 1.030.12 0.590.19 1.94 4.07 21.19 39.07 4816.73 362.86 108.92 50.93
21 3.04 3.87 13.811.72 23.221.96 0.830.33 0.800.85 2.93 5.88 8.82 18.8 173.60 141.10 4812.05 3920.97
22 3.85 3.66 21.171.69 20.181.15 1.000.11 0.740.08 2.78 4.48 18.34 13.32 5316.21 318.37 336.93 145.75
23 3.15 4.76 11.690.52 14.902.23 0.670.21 0.420.39 5.1 3.5 38.58 50.16 7534.75 10742.68 7113.66 8819.65
24 3.74 3.84 16.131.27 15.772.82 0.780.07 0.550.24 4.3 5.72 27.4 21.76 425.80 555.07 324.50 254.56
25 3.84 4.07 13.592.63 31.723.47 0.640.25 1.040.03 2.42 4.6 11.51 21.78 30.43 20.10 142.86 4031.24
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optical density values, indicative of slower growth. In general,
lower resveratrol production yields were obtained when the cells
are more depolarized, as can be seen in assays 20 and 23 (Table 2),
as 39.07% and 50.16% of depolarized cells yielded 15.90mg/mL and
14.90mg/mL of resveratrol, respectively that also corresponded to
low resveratrol speciﬁc productivities, 0.59 and 0.42mg/gh1,
respectively. Nevertheless, there were some exceptions to this
fact, meaning that resveratrol production was also dependent on
the growth conditions. This assumption can be observed in assay
15, where despite the high values of depolarization (31.1%),
109.28mg/mL (6.31mg/gh1) of resveratrol were obtained, which
can be explained by the possible trans-resveratrol degradation in
culture medium due to the growth conditions [27].
Temperature, as one of the most important factors in cell
growth, also inﬂuenced cellular viability, as half of the assays with
more than 30% of depolarized cells were performed either at 34 C
(assays 17, 18, 20, 23). Apparently, precursor concentration
seemed to affect cellular viability, as can be seen in assay 15,
where the addition of 16mM of p-coumaric acid caused an
increase in the percentage of depolarized cells. This decreased
cellular viability could be due to the higher concentration of
p-coumaric acid added to the culture, which may cause a
destabilization of the cell membrane [28] by altering the dynamics
of phospholipid chains [28]. However, other factors may also be
involved in the increase of the percentage of cells with depolarized
membranes, since some assays the raise in precursor concentra-
tion was not associated with this behaviour (Table 2). The results
obtained showed that culture conditions could affect cellular
viability which, in turn, affected resveratrol production, as lower
percentage of healthy cells yielded lower resveratrol production at
the end of fermentations.
3.4. Plasmid segregational stability
In a production bioprocess, the aim is to fully exploit the host
cell’s capacity for recombinant protein synthesis. According to
Grabherr et al. [15], protein production is based on appropriate
gene expression, high copy number plasmids, and optimized
growth conditions during the process.
Based on this, measuring plasmid segregational stability
through PCN variation throughout the fermentation may also
provide new insights and allow a more comprehensive under-
standing of resveratrol production, helping to deﬁne the best
conditions to obtain the highest yield. In the majority of these
assays, PCN increases both in pAC-4CL1 and pUC-STS from 22 to
30h (Table 2), which could partially explain the higher resveratrol
production yields also obtained in the samples taken after 30h of
fermentation. Absolute PCN values for pUC-STS (high copy number
plasmid) are also lower in comparison with pAC-4CL1 (low copy
number plasmid) values, indicating that the production of stilbene
synthase could be the limiting step of this resveratrol production
process, since high copy number plasmids perform a deﬁcient
regulation of gene expression, sometimes resulting in a residual
production of protein [29]. The PCN values reported in this work
are lower than the ones described by other studies using E. coli
recombinant systems [13]. This fact could be related with the
metabolic burden imposed to the E. coli cell by the maintenance
and replication of two plasmids which resulted in lower cell
growth and PCN values, indicating a possible increase in plasmid
segregational instability, which may lead to plasmid loss [14].
Although in some assays, it is possible to observe a positive
correlation between total PCN values and resveratrol speciﬁc
productivity (assays 2, 3, 13, and 25), there are others where the
opposite relation is observed (assays 10 and 15). Therefore, it was
not possible to establish a relation between PCN and resveratrol
productivity which can be due to the fact that this is a dual plasmid
system and that resveratrol, being produced as an extracellular
product, can be deteriorated by the culture conditions used as
already discussed above.
4. Conclusions
This study describes resveratrol production by E. coli
BW27784 containing pAC-4CL1 and pUC-STS plasmids and the
assessment of physiological states and plasmid segregational
stability during bioreactor cultivation. Resveratrol yield was
greatly inﬂuenced by culture conditions as a result of the possible
interactions established between the culture conditions on
opposite to a linear variation for each condition tested and
resveratrol yields. Cellular viability also showed to impact
resveratrol production since growth conditions inﬂuenced physi-
ological states. p-Coumaric acid played a critical role in resveratrol
production, since it inﬂuenced the cellular viability due to
interactions with the cell membrane, which affected the percen-
tages of healthy cells and consequent resveratrol volumetric yields.
Monitoring resveratrol production is also important due to its
ability to inﬂuence cellular viability caused by its inherent
antimicrobial properties. The presence of two plasmids within
the same cell inﬂuenced the ﬁnal yield, because the metabolic
burden generated might result in decreased cellular viability.
Plasmid segregational stability evaluation revealed that no
apparent relationship was obtained between plasmid copy
number and resveratrol yields. In sum, this study indicates that
these monitoring tools might be considered for a comprehensive
application to resveratrol bioprocesses, in order to optimize and
choose the most suitable design to create a valuable alternative to
chemical synthesis.
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